期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Diabetes epidemic in the Asia pacific region:has hemoglobin A1C finally earned its place as a diagnostic tool? 被引量:4
1
作者 Alexandra Bagley Usman H.Malabu 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2014年第2期85-89,共5页
Two-third of the world's population lives in the Asia Pacific region where prevalence of diabetes has reached epidemic proportion.With China and India being the most populous nations on the globe,it is believed th... Two-third of the world's population lives in the Asia Pacific region where prevalence of diabetes has reached epidemic proportion.With China and India being the most populous nations on the globe,it is believed that over 150 million diabetes reside in the region with more than 95%being of type 2 diabetes mellitus(T2DM).Furthermore,other Pacific islands in the region have high rales of T2DM including Tonga.Fiji.French Polynesia,and Nauru.The latter has the highest prevalence of T2DM per population in the world.Over the past two decades,in Australia and New Zealand,the prevalence of T2DM has more than doubled,mainly amongst the Aboriginal and Torres Strait Islander and Maori peoples respectively.With the increasing prevalence of dialietes in the Asia Pacific region coupled with the limited number of resources,use of a reliable and effective mode of diagnosis for T3DVI is warranted.Yet to date,only New Zealand has adopted the American Diabetes Association recommendation of using hemoglobin A1C in the diagnosis of the disease.The aim of this review is to discuss the clinical usefulness of hemoglobin A1C and highlight its diagnostic role in the Asia Pacific region where T2DM is increasingly encountered. 展开更多
关键词 hemoglobin aic Diagnostic tool Asia PACIFIC REGION
暂未订购
Westgard西格玛规则在糖化血红蛋白检验项目室内质量控制中的选择应用 被引量:22
2
作者 张诗诗 王薇 +1 位作者 赵海建 王治国 《现代检验医学杂志》 CAS 2016年第2期157-160,共4页
目的运用Westgard西格玛规则帮助临床实验室选择适合糖化血红蛋白(HbAlC)检验项目的室内质量控制(质控)规则。方法在参加2015年卫生部临床检验中心HbAlC室间质量评价(EQA)和室内质控(IQC)计划的所有实验室中按地区(华北、华中... 目的运用Westgard西格玛规则帮助临床实验室选择适合糖化血红蛋白(HbAlC)检验项目的室内质量控制(质控)规则。方法在参加2015年卫生部临床检验中心HbAlC室间质量评价(EQA)和室内质控(IQC)计划的所有实验室中按地区(华北、华中、华东等)随机选取10家,把每家实验室在EQA计划中的百分差值当作其偏倚(bias)的估计值,在IQC计划中的累积变异系数当作其不精密度(CV的估计值。以生物学变异导出的适当要求、美国病理家学会(CAP)、中国EQA计划中的允许总误差(TEa)作为质量规范,利用公式σ=[(TEa—|bias|)/CV]计算σ值,结合Westgard西格玛规则为各实验室HbAlC检验项目选择正确的质控规则。结果使用基于生物学变异的TEa,各实验室σ值均〈2,应选1 3s/2 2s/R 4s/4 1s/规则。使用源自CAP的TEa,2号实验室σ值为5.04,应选1 3s/2 2s/R4s规则;其余实验室σ值均〈4,应选1 3s/22,/R4s/4 1s/规则。使用我国EQA计划可接受限作为TEa,2号实验室σ值〉6,应选1 3s规则;1号实验室σ值为5.45,应选1 3s/2 2s/R4s规则;6,10号实验室σ值分别为4.76和4.18,应选1 3s/2 2s/R 4s/4 1s规则;其余实验室σ值均〈4,应选1 3s/2 2s/R 4s/4 1s/规则。结论临床实验室可以运用简便快捷的Westgard西格玛规则为检验项目选择正确的质控规则。 展开更多
关键词 Westgard西格玛规则 糖化血红蛋白 室内质量控制 质控规则
暂未订购
2项检测对2型糖尿病并发糖尿病足的意义 被引量:3
3
作者 梁艳 蒋兴亮 +2 位作者 雷燕 邹家琼 敬鹏 《检验医学与临床》 CAS 2013年第10期1221-1222,共2页
目的通过分析2型糖尿病(T2DM)患者糖化血红蛋白(HbA1c)和生化检测指标,以探讨T2DM并发糖尿病足(DFU)发病的危险因素,为临床诊治提供指导。方法选取178例T2DM患者,其中78例为糖尿病足患者(DF组),100例为2型糖尿病患者无糖尿病足(DC组)。... 目的通过分析2型糖尿病(T2DM)患者糖化血红蛋白(HbA1c)和生化检测指标,以探讨T2DM并发糖尿病足(DFU)发病的危险因素,为临床诊治提供指导。方法选取178例T2DM患者,其中78例为糖尿病足患者(DF组),100例为2型糖尿病患者无糖尿病足(DC组)。分别测定HbA1c和血压一般生化指标:同型半胱氨酸(Hcy)、脂蛋白a[LP(a)]、载脂蛋白B(Apo B)和空腹血糖(FBG)等。然后比较两组各指标间的差异,采用Loges-tic分析具有差异的指标。结果 DC组和DF组Hcy、HbA1c和LP(a)等7项指标差异有统计学意义(P<0.05)。HbA1c(OR=2.01)和Hcy(OR=1.85)为T2DM患者发生足部溃疡的主要危险因素。结论在普通生化检测指标中Hcy及血浆HbA1c的检测对DFU的诊治最具指导意义。 展开更多
关键词 糖化血红蛋白 同型半胱氨酸 2型糖尿病 糖尿病足
暂未订购
Comparison of glycemic variability and glycated hemoglobin as risk factors of coronary artery disease in patients with undiagnosed diabetes 被引量:18
4
作者 MI Shu-hua SU Gong +5 位作者 LI Zhao YANG Hong-xia ZHENG Hong TAO Hong ZHOU Yun TIAN Lei 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第1期38-43,共6页
Background The role of chronic hyperglycaemia as a coronary artery disease (CAD) risk factor is well-known, and the glycemic variability is still a matter of debate. The aim of this study was to investigate the asso... Background The role of chronic hyperglycaemia as a coronary artery disease (CAD) risk factor is well-known, and the glycemic variability is still a matter of debate. The aim of this study was to investigate the association of admission glycemic excursion and hemoglobin Alc (HbA1c) with the presence and severity of CAD in patients with undiagnosed diabetes mellitus (DM). Methods We studied 286 newly diagnosed DM patients without prior revascularization undergoing coronary angiography for suspected ischaemic chest pain. Patients were grouped into those with CAD and without CAD according to angiographic results. The severity of CAD was assessed using the Gensini score. Glycemic variability, indicated as the mean amplitude of glycemic excursions (MAGE), was determined by a continuous glucose monitoring system. Serum levels of HbA1c and high-sensitive C-reactive protein (hs-CRP) as well as plasma concentrations of fasting glucose, lipids and creatinine were measured in all patients. Predictors of CAD were determined using multivariate Logistic regression model and receiver-operating characteristic (ROC) curves. Results The newly diagnosed DM patients with CAD were older, and more were male and current cigarette smokers compared with the patients without CAD. The CAD group had significantly higher levels of MAGE and HbA1c. Individuals with high levels of HbA1c (〉7%) or MAGE (〉3.4 mmol/L) had also significantly higher CAD prevalence. Logistic regression analysis revealed that high MAGE level and high HbA1c level were independent predictors for CAD. The area under the receiver-operating characteristic curve for MAGE (0.606, P=0.005) was superior to that for HbA1c (0.582, P=0.028). Gensini score closely correlated with age, MAGE, HbA^c, hs-CRP, creatinine and total cholesterol. Multivariate analysis indicated that age (P 〈0.001), MAGE (P 〈0.001), HbA1c (P=0.022) and hs-CRP (P=0.005) were independent determinants for Gensini score. Conclusions Both admission glycemic excursion and chronic hyperglycaemia are associated with the severity of CAD in newly diagnosed DM patients. MAGE displays a significant value in predicting CAD in patients with undiagnosed diabetes even more than HbA1c. 展开更多
关键词 glycemic variability hemoglobin aic coronary artery disease diabetes mellitus
原文传递
Efficacy and safety of insulin treatment in type 2 diabetes using a new index called glucose safety control index
5
作者 Cai Xiao-ling Luo Ying-ying +1 位作者 Han Xue-yao Ji Li-nong 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第21期4166-4174,共9页
Objective To recommend an index named glucose safety control index (GSCI) to evaluate the efficacy and safety for insulin regimens. Data sources We searched databases for primary studies published in English. The ma... Objective To recommend an index named glucose safety control index (GSCI) to evaluate the efficacy and safety for insulin regimens. Data sources We searched databases for primary studies published in English. The main search concepts were type 2 diabetes, insulin treatment, premixed insulin, premixed insulin analogs, basal inuslin, basal inuslin analogs, bolus insulin, bolus insulin analogs, safety and efficacy. 展开更多
关键词 hemoglobin aic hypoglycemia type 2 diabetes
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部